Appl Environ Microbiol, July 1998, p. 2454-2462, Vol. 64, No. 7
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Institut für Mikrobiologie und Genetik, Georg-August-Universität, 37077 Göttingen, Germany
Received 8 January 1998/Accepted 27 April 1998
Pseudomonas sp. strain JR1 exhibits trichloroethene
(TCE) oxidation activity with isopropylbenzene (IPB) as the inducer
substrate. We previously reported the genes encoding the first three
enzymes of the IPB-degradative pathway (ipbA1,
ipbA2, ipbA3, ipbA4,
ipbB, and ipbC) and identified the initial IPB
dioxygenase (IpbA1A2A3A4) as responsible for TCE cooxidation
(U. Pflugmacher, B. Averhoff, and G. Gottschalk, Appl. Environ.
Microbiol. 62:3967-3977, 1996). Primer extension analyses revealed
multiple transcriptional start points located upstream of the
translational initiation codon of ipbA1. The transcription
from these start sites was found to be IPB dependent. Thirty-one base
pairs upstream of the first transcriptional start point tandemly
repeated DNA sequences overlapping the
35 region of a putative
70 promoter were found. These repeats exhibit
significant sequence similarity to the operator-promoter region of the
xyl meta operon in Pseudomonas putida, which is
required for the binding of XylS, a regulatory protein of the XylS
(also called AraC) family. These similarities suggest that the
transcription of the IPB dioxygenase genes is modulated by a regulatory
protein of the XylS/AraC family. The construction of an ipb
DNA module devoid of this ipb operator-promoter region and
the stable insertion of this DNA module into the genomes of different
Pseudomonas strains resulted in pseudomonads with constitutive IPB and TCE oxidation activities. Constitutive TCE oxidation of two such Pseudomonas hybrid strains,
JR1A::ipb and CBS-3::ipb,
was found to be stable for more than 120 generations in antibiotic-free
medium. Evaluation of constitutive TCE degradation rates revealed that
continuous cultivation of strain JR1A::ipb resulted in a significant increase in rates of TCE degradation.
Present address: Bayer AG, Zentrale Forschung-Biotechnologie,
D-51368 Leverkusen, Germany.
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|